Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of 1,2-Dibromo-2,4-dicyanobutane M950118

CASRN: 35691-65-7

Formula: C6-H6-Br2-N2

Synonyms/Common Names

  • 2-Bromo-2-(bromomethyl)glutaronitrile
  • 2-Bromo-2-(bromomethyl)pentanedinitrile
  • Dibromodicyanobutane
  • Metacide 38
  • Methyldibromoglutaronitrile
  • Tektamer 38

Short-Term Toxicity

  • 2 weeks (Gavage)  (C97003)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R: 0, 37, 75, 150, 300, OR 600 MG/KG; M: 0, 75, 150, 300, 600, OR 1200 MG/KG; 5/SEX/SPECIES/DOSE.
  • 2 weeks (Topical Application)  (C97003B)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R: 0, 37, 75, 150, 300, OR 600 MG/KG (GIVEN IN TWO DOSES); M: 0, 75, 150, 300, 600, OR 1200 MG/KG; 5/SEX/SPECIES/DOSE.
  • 13 weeks (Topical Application)  (C97003C)  Completed 
    • Rats: F344/N; Mice: B6C3F1/N
    • Dose: R&M: 0, 0.2, 0.6, 2, 6, OR 18 MG/KG, 5X PER WEEK; 10/SEX/DOSE.

Long-Term Carcinogenicity

  • 2 years (Topical Application)  (C97003D)  Completed 
    • TR-555 (NIH Number: 10-5896)  (Peer Review Approval 02/27/2008A )
      Toxicology and Carcinogenesis Studies of 1,2-Dibromo-2,4-dicyanobutane (CASRN 35691-65-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies)
    • Rats: F344/N; Mice: B6C3F1/N
    • Dose: R: 0, 2, 6, OR 18 MG/KG AND M: 0, 0.6, 2, OR 6 MG/KG; 50/SEX/SPECIES/D0SE.
    • Carcinogenesis Results
      • Male Rats No Evidence 
      • Female Rats No Evidence 
      • Male Mice No Evidence 
      • Female Mice No Evidence 

Special Studies

  • Mechanisms (Intravenous)  (S0783)  Completed 
    • Citation: Sauer JM, Smith RL, Bao J, Kattnig MJ, Kuester RK, Sipes IG. Metabolic and dispositional fate of 1,2-dibromo-2,4-dicyanobutane in the male fischer 344 Rat. Drug Metab Dispos. 1998 May;26(5):429-36.Pubmed Abstract
    • Male Rats [R]: F344/N
  • Mechanisms (Intraperitoneal Injection)  (S0784)  Completed 
    • Citation: Bao J, Sauer JM, Smith RL, Kuester RK, Kattnig MJ, Sipes IG. Sulfhydryl-dependent biotransformation and macromolecular binding of 1,2-dibromo-2,4-dicyanobutane in blood. Drug Metab Dispos. 1998 Oct;26(10):1001-7.Pubmed Abstract
    • Male Rats [R]: F344/N
  • Metabolism (Intravenous)  (S0806)  Completed 
    • Citation: Bao J, Sauer JM, Smith RL, Kuester RK, Kattnig MJ, Sipes IG. Sulfhydryl-dependent biotransformation and macromolecular binding of 1,2-dibromo-2,4-dicyanobutane in blood. Drug Metab Dispos. 1998 Oct;26(10):1001-7.Pubmed Abstract
    • Male Rats [R]: F344/N
    • Dose: [14C]BCB (80 mg/kg, 120 uCi/kg, 2 ml/kg), in a vehicle of 10% emulphor/15% ethanol/75% saline solution was administered via the indwell-ing jugular vein cannula..
  • Metabolism (Gavage; Topical Application; Intravenous)  (S0807)  Completed 
    • Citation: Sauer JM, Smith RL, Bao J, Kattnig MJ, Kuester RK, Sipes IG. Metabolic and dispositional fate of 1,2-dibromo-2,4-dicyanobutane in the male fischer 344 Rat. Drug Metab Dispos. 1998 May;26(5):429-36.Pubmed Abstract
    • Male Rats [R]: F344/N
    • Dose: [14C]BCB (8 mg/kg, 120 uCi/kg), in emulphor/ethanol/saline, 3:4:12 (v/v/v) was administered via a jugular vein cannula; [14C]BCB (80 mg/kg, 100 uCi/kg) in corn oil (5 ml/kg) was administered orally by gavage; 100 ul of [14C]BCB (25 mg/kg, 50 uCi/kg) in ethanol/propylene glycol, 3:7 (v/v) was applied to the shaved backs of the animals..

Genetic Toxicology

  • Micronucleus  (A65692)  Completed 
    • Mice: B6C3F1
    • Male Negative 
    • Female Negative 
  • Salmonella  (A11889)  Completed 
    •  Negative 
  • Salmonella  (A92777)  Completed 
    •  Negative